Find Information on a:
View all Postings for:
Search ClotCare
|
Postings on Direct Thrombin Inhibitors
For Patients and Caregivers
For Health Care Providers
|
Posting
|
Date Posted
|
|
Medication Errors in Cardiovascular & Stroke Patients
|
June, 2010
|
|
Subcutaneous Direct Thrombin Inhibitor (Desirudin) Approved for Prevention of DVT in the US; Shown to be Superior to Heparin and Enoxaparin
|
March, 2010
|
|
Dabigatran vs. Warfarin in Atrial Fibrillation; Reluctant to Rely on RE-LY
|
March, 2010
|
|
Video: Current and Emerging Trends in DVT Prophylaxis
|
October, 2009
|
|
Dietary and Herbal Supplements in Patients on Anticoagulation – Serious Unknowns and an Online Registry to Help
|
February, 2008
|
|
Anticoagulation Safety a Hospital Priority for 2008
|
January, 2008
|
|
Dietary Supplements & Oral Anticoagulants - A Registry of Interactions
|
August, 2007
|
|
Bivalirudin for Non-ST-segment Elevation Acute Coronary Syndrome: A Discussion on the Results of the ACUITY Trial
|
May, 2007
|
|
Can better INR control be achieved, and if so, how will new anticoagulants compare to warfarin (Coumadin)?
|
March, 2007
|
|
Variation in reagent sensitivities confounds use of the aPTT with UFH, DTI, and the combination
|
January, 2007
|
|
The Pulmonary Embolism Support Group - Support for Individuals with DVT or PE
|
January, 2007
|
|
Update on Treatment and Prevention of Pulmonary Embolism
|
August, 2006
|
|
Is it safe to omit additional tests is d-Dimer is negative?
|
August, 2006
|
|
AstraZeneca Decides to Withdraw Exanta
|
February, 2006
|
|
NIH Conference on Dietary Supplements, Coagulation, and Antithrombotic Therapies
|
March, 2005
|
|
What Happened to Ximelagatran?
|
March, 2005
|
|
FDA Rejects Ximelagatran (brand name Exanta)
|
October, 2004
|
|
New Supplement Devoted to Unfractionated Heparin
|
August, 2004
|
|
Anticoagulation in Special Populations
|
August, 2004
|
|
An Overview of Anticoagulants, Antiplatelet Agents, and the Combination in Patients with Mechanical Heart Valves
|
May, 2004
|
|
New Anticoagulants to Displace or Reshape Anticoagulation Clinics
|
April, 2004
|
|
Leading Authority Reviews Advances in Pulmonary Embolism Diagnosis and Treatment
|
April, 2004
|
|
Low Molecular Weight Heparin Preferred for Pulmonary Embolism?
|
February, 2004
|
|
Ximelagatran (brand name Exanta) is Leading the Coming Revolution in Stroke Prevention in Atrial Fibrillation -- Two New Studies
|
January, 2004
|
|
|
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.
|